|
EP3434265B1 |
07 Jul, 2021
|
Pharmaceutical Composition Containing Rifaximin Alpha & Delta
|
Mar, 2037
|
3
| |
|
EP3294270B1 |
12 Sep, 2018
|
Pharmaceutical Composition Containing Rifaximin Alpha&Delta
|
Mar, 2037
|
2
| |
|
EP3373914B2 |
01 Jun, 2022
|
Storage Stable Composition Comprising Rifaximin Alpha
|
NA
|
1
| |
|
EP3536311B1 |
22 Dec, 2021
|
Storage Stable Composition Comprising Rifaximin Alpha
|
Mar, 2037
|
1
| |
|
EP3390358B1 |
23 Sep, 2020
|
Crystalline Eravacycline Bis-Hydrochloride
|
Jan, 2037
|
1
| |
|
EP3416627B9 |
22 Apr, 2020
|
Oral Dosage Form Comprising Rifaximin In Form Beta
|
NA
|
1
| |
|
EP2785702B1 |
22 Jan, 2020
|
Crystalline Dapagliflozin Hydrate
|
NA
|
1
| |
|
EP2975050B1 |
29 May, 2019
|
Quantification Of Misfolded Tnfr2:Fc
|
NA
|
1
| |
|
EP2977372B1 |
08 May, 2019
|
Polymorphs Of Febuxostat
|
Jun, 2031
|
1
| |
|
EP2988733B1 |
27 Mar, 2019
|
Pharmaceutical Composition Containing Crystalline Macitentan
|
NA
|
1
| |
|
EP3003277B1 |
20 Feb, 2019
|
Process For The Preparation Of A Pharmaceutical Composition Comprising Rivaroxaban
|
May, 2034
|
1
| |
|
EP2882424B1 |
13 Dec, 2017
|
Stable Pharmaceutical Composition Containing 8-[(3R)-3-Amino-1-Piperidinyl]-7-(2-Butyn-1-Yl)-3,7-Dihydro-3-Methyl-1-[(4-Methyl-2-Quinazolinyl)Methyl]-1H-Purine-2,6-Dione Or A Pharmaceutically Acceptable Salt Thereof
|
NA
|
1
| |
